Last year, your generosity helped raise over $600,000 for biomarker research. One year on, that impact is already being felt and gaining attention around the world.
Dr Tahlia Sheinberg and her team are continuing to develop a simple blood test to help personalise treatment for men with advanced prostate cancer. Over the past year, Dr Sheinberg has been invited to present her research at leading international events, including the European Society for Medical Oncology (ESMO) and the Prostate Cancer Foundation Scientific Retreat in the United States.
To do this, she created a series of scientific posters. This is a key way researchers share new discoveries with experts from around the world. Each poster brings together years of careful work, transforming complex laboratory results and patient data into a clear visual story.
These presentations allow other scientists to understand the findings, ask questions, and explore how the research could be applied in future studies and patient care. Being selected to present at these conferences is a strong sign of the quality and importance of a researcher's work.
“We’re learning that tiny molecules in the blood can help predict which treatments will work best for each patient,” explains Dr Sheinberg. “Sharing this research internationally helps move us closer to truly personalised cancer care.”
Research at Chris O’Brien Lifehouse is not only advancing patient care locally but is being recognised and respected on the world stage.
Your generosity is helping turn promising ideas into meaningful progress. You are supporting researchers who are shaping the future of personalised cancer care and improving outcomes for patients everywhere.
